Microbiología y Parasitología
Departamento
Hospital Universitario Doctor Peset
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (17)
2022
-
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
Antibiotics, Vol. 11, Núm. 9
2018
-
Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy
Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100
-
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577
2017
-
Quality of the aetiological diagnosis of ventilator-associated pneumonia in Spain in the opinion of intensive care specialists and microbiologists
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 3, pp. 153-164
2013
-
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy
Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326
-
Risk factors and effectiveness of preventive measures against influenza in the community
Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183
2012
-
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization
Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439
-
Pneumonia treated in the internal medicine department: Focus on healthcare-associated pneumonia
Clinical Microbiology and Infection, Vol. 18, Núm. 8, pp. 786-794
-
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745
2011
-
Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Clinical Microbiology and Infection, Vol. 17, Núm. SUPPL. 2, pp. 1-24
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959
-
Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 3
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
2003
-
Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)
Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 421-427
-
Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults
Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 5, pp. 826-836
-
Pseudomonas aeruginosa: Estudio multicéntrico en 136 hospitales Españoles
Revista Espanola de Quimioterapia, Vol. 16, Núm. 1, pp. 41-52
2002
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy